In our latest Trade to Black podcast, hosts Shadd Dales and Anthony Varrell dive into the latest cannabis industry buzz. First up, New York might soon let you pair your popcorn with a puff. State officials are exploring plans to allow marijuana sales and consumption at movie theaters. With $1 billion in cannabis sales already, New York is aiming to make cannabis a true blockbuster. Next, Curaleaf (OTCQX: CURLF) is shaking up the hemp beverage market with Select FormulaX—a THC and caffeine-infused energy drink. Designed for modern multitaskers, this fast-acting drink is perfect for gamers, festival-goers, and thrill-seekers. Finally, Innovative Industrial Properties (NASDAQ: IIPR) faces challenges as it restructures its portfolio, addressing tenant defaults and financial hurdles in a turbulent cannabis economy. Plus, Michael Bronstein from the American Trade Association for Cannabis and Hemp joins us to discuss Sara Carter’s appointment as President Trump’s new Drug Czar and its implications for the industry. 0:00:00 - Intro0:00:24 - Trump's New Drug Czar0:02:36 - NY Weed in Theaters0:06:04 - Curaleaf's New Energy Drink (Select Formula X)0:12:13 - IIPR Default Issues0:17:13 - Insider's Edge Segment0:18:53 - Sara Carter's appointment as Drug Czar0:35:28 - Potential political implications of cannabis rescheduling0:35:28 - Cannabis Rescheduling Impact0:41:14 - Sara Carter Wrap-Up0:43:42 - Wrap up & Upcoming Guests#CannabisNews #DonaldTrump #MarijuanaNews #CannabisIndustry #Curaleaf #THCEnergyDrink #CannabisStocks #NewYorkCannabis #IIPR #HempBeverages #CannabisEconomy #cannabisreform Want to see last week's recap?   • TDR’s Biggest Developments in Cannabi...  Want to see more Cannabis Reform videos?   • Texas Hemp: Cracking Down On a Big Pr...     • Cannabis Legalization: Why Your Opini...     • DEA Bias Complicates Cannabis Resched...     • How The US Mistakenly Legalized Marij...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:   / thedalesreport  Twitter:   / thedalesreport  Instagram:   / dalesreport  LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:[email protected] views on the Trade To Black podcast and the guests on this podcast are purely opinions. You should not treat any opinions expressed by us or our guests as investment advice. The views on this podcast are solely intended to be informational and are not investment advice. Please go to our website for a full list of disclosures and details of any client relationship we have. https://thedalesreport.com/website-te...

In our latest episode of Trade to Black, hosts Shadd Dales and Anthony Varrell welcome Zach George, CEO of SNDL (NASDAQ: SNDL) to the podcast. Zach will dive into SNDL’s latest cannabis earnings report, which showcased record-breaking numbers, including $257.7 million in Q4 revenue and $920.4 million for the full year, which represented a 1.3% increase year over year. The conversation also explores SNDL’s recent filing, revealing their acquisition of 5.4% of High Tide’s (NASDAQ: HITI) outstanding shares. Shadd and Anthony will ask Zach about the strategic reasoning behind this investment, its implications for both companies, and whether a potential takeover could be on the horizon.In the second half, Shadd and Anthony welcome Marvin Washington, advisor to Leafwell🍃 and former Super Bowl champion with the Denver Broncos. Marvin will discuss the evolving role of cannabis in sports leagues, emphasizing why MLB and the NBA are poised to lead the charge, leaving the NFL trailing behind. He’ll also share insights into his ties with Weldon Angelos and the potential for criminal justice reform within the cannabis industry under the Trump administration.#CannabisLegalization #Cannabis #Marijuana #SNDL #HighTide #NBA #NFL #MLB #CannabisStocks #CannabisEarnings #CannabisNews #CannabisLegislation

Want to see last week's recap?   • TDR’s Biggest Developments for the We...  Want to see more Cannabis Reform videos?   • Cannabis Legalization: Why Your Opini...     • DEA Bias Complicates Cannabis Resched...     • How The US Mistakenly Legalized Marij...     • Understanding Hemp vs. Cannabis: What...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:   / thedalesreport  Twitter:   / thedalesreport  Instagram:   / dalesreport  LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:[email protected] views on the Trade To Black podcast and the guests on this podcast are purely opinions. You should not treat any opinions expressed by us or our guests as investment advice. The views on this podcast are solely intended to be informational and are not investment advice. Please go to our website for a full list of disclosures and details of any client relationship we have. https://thedalesreport.com/website-te...

In the latest episode of Trade to Black, hosts Shadd Dales and Anthony Varrell dive into their recent trip to Washington, D.C., uncovering the latest updates on cannabis rescheduling. The sentiment is clear: while President Trump supports rescheduling, some in his administration resist, including Senator Tim Scott, framing this as a political issue rather than one rooted in science.They also European cannabis market, where international players are leading the deregulatory wave. The message? Unity and harmonization are key. In the U.S., hemp and regulated marijuana must align under a single agenda to showcase the industry as a responsible actor.Globally, the U.S. risks losing its leadership in a multi-billion-dollar industry due to stigma and lack of focus. Former Congressman Matt Gaetz’s recent article highlights the need to downgrade marijuana to Schedule III, emphasizing science over stigma

0:00:00 - Introduction and Trip to Washington

0:01:09 - European Cannabis Market Insights

0:03:09 - Rescheduling Discussion

0:06:31 - Global Perspectives on Cannabis

0:08:35 - Medical vs. Recreational Cannabis

0:13:10 - American Rights and Reform Pack Campaign

0:22:12 - Political Influence and Rescheduling

0:32:28 - Future of Cannabis Legislation

0:39:57 - Closing Remarks on EU Market and Research Potential

0:40:21 - Hemp Industry and Farm Bill Discussion

#CannabisRescheduling #CannabisStocks #GlobalCannabis #CannabisLeadership #CannabisIndustry #CannabisLegalization #CannabisPolicy #CannabisReform #CannabisAdvocacy #Trump #trumpadministration

Want to see last week's recap?   • TDR’s Biggest Developments for the We...  Want to see more Cannabis Reform videos?   • Cannabis Legalization: Why Your Opini...     • DEA Bias Complicates Cannabis Resched...     • How The US Mistakenly Legalized Marij...     • Understanding Hemp vs. Cannabis: What...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:   / thedalesreport  Twitter:   / thedalesreport  Instagram:   / dalesreport  LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:[email protected] views on the Trade To Black podcast and the guests on this podcast are purely opinions. You should not treat any opinions expressed by us or our guests as investment advice. The views on this podcast are solely intended to be informational and are not investment advice. Please go to our website for a full list of disclosures and details of any client relationship we have. https://thedalesreport.com/website-te...

Shadd Dales and Anthony Varrell dive into major developments in the cannabis industry. We have major headlines from the state of Florida, where Curaleaf has plans to launch a hemp dispensary in Palm Beach, and it has been uncovered that Ron DeSantis took $500k in donations from Phillip Morris International to fight Amendment 3. Also, Michael Bronstein from the American Trade Association for Cannabis and Hemp will join us for the weekly Insiders Edge segment to provide updates on the fight for hemp in the State of Texas.Want to see last week's recap?   • TDR’s Biggest Developments for the We...  Want to see more Cannabis Reform videos?   • Cannabis Legalization: Why Your Opini...     • DEA Bias Complicates Cannabis Resched...     • How The US Mistakenly Legalized Marij...     • Understanding Hemp vs. Cannabis: What...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:   / thedalesreport  Twitter:   / thedalesreport  Instagram:   / dalesreport  LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:[email protected] views on the Trade To Black podcast and the guests on this podcast are purely opinions. You should not treat any opinions expressed by us or our guests as investment advice. The views on this podcast are solely intended to be informational and are not investment advice. Please go to our website for a full list of disclosures and details of any client relationship we have. https://thedalesreport.com/website-te...

In this episode of the Trade to Black podcast, Shadd Dales and Anthony Varrell welcome Cresco Labs (OTCQX: CRLBF) CEO Charlie Bachtell to discuss the company’s Q4 and full Fiscal 2024 results. Cresco Labs posted $724 million in annual revenue, reflecting a 6% decline from the previous year, but demonstrated resilience by maintaining adjusted gross profit levels consistent with 2023. Adjusted EBITDA improved 15% year-over-year, reaching $200 million, while operating cash flow rose $74 million to $132 million. Capital expenditures were managed at $20 million, and the company reduced its debt by retiring $40 million of its 2026 note in Q4.Despite these achievements, Cresco faced challenges, including price compression in key markets like Illinois and Pennsylvania, which impacted wholesale revenue and margins. We learn what the 3 main takeaways from Cresco Labs' earnings, as well what cannabis investors should avoid focusing on in the cannabis industry in 2025. Plus, Viridian Capital Advisors CFA, Frank Colombo joins us again to recap the latest cannabis earnings season. He’ll highlight standout performers, address ongoing concerns in the sector, and share his perspective on what investors should focus on moving forward.#stockmarket #cannabisstocks #cannabisearnings #stocks #earnings #topcannabisstocks #potstocks #weedstocks #cannabis #marijuana #cannabistrends #cannabisnewsWant to see last week's recap?   • TDR’s Biggest Developments for the We...  Want to see more Cannabis Reform videos?   • Cannabis Legalization: Why Your Opini...     • DEA Bias Complicates Cannabis Resched...     • How The US Mistakenly Legalized Marij...     • Understanding Hemp vs. Cannabis: What...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:   / thedalesreport  Twitter:   / thedalesreport  Instagram:   / dalesreport  LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:[email protected] views on the Trade To Black podcast and the guests on this podcast are purely opinions. You should not treat any opinions expressed by us or our guests as investment advice. The views on this podcast are solely intended to be informational and are not investment advice. Please go to our website for a full list of disclosures and details of any client relationship we have. https://thedalesreport.com/website-te...

Shadd Dales and Anthony Varrell welcome Will Muecke and Stanton McLean, Co-Founders and Managing Members of Artemis Growth Partners.Together, they’ll dive into the upcoming Global Cannabis Regulatory Summit being held in Washington D.C. from March 25-27.The cannabis industry event will be designed to unite global regulators of legal medical cannabis. The discussion will also include the importance of collaboration between the European and American cannabis markets to promote awareness for industry growth. Will and Stanton will explain why matching regulations and improving communication can advance cannabis reform and ultimately benefit the cannabis industry worldwide.Additionally, Christian Angermayer, Chairman of atai Life Sciences (NASDAQ: ATAI), will be featured in our weekly segment, *Psychedelic Market Minute*. We’ll highlight atai’s latest earnings and discuss the future of the psychedelic industry, particularly in light of Robert Kennedy Jr.’s appointment as head of Human Health and Services. #cannabis #cannabisindustry #cannabisregulation #medicalmarijuana #marijuana #psychedelics #psychedelicindustry #rfk #cannabisstocks #weed #psychedelicstocksWant to see last week's recap?   • TDR’s Biggest Developments for the We...  Want to see more Cannabis Reform videos?   • DEA Bias Complicates Cannabis Resched...     • How The US Mistakenly Legalized Marij...     • Understanding Hemp vs. Cannabis: What...     • Why Trump Says Cannabis Legalization ...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:   / thedalesreport  Twitter:   / thedalesreport  Instagram:   / dalesreport  LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:[email protected] views on the Trade To Black podcast and the guests on this podcast are purely opinions. You should not treat any opinions expressed by us or our guests as investment advice. The views on this podcast are solely intended to be informational and are not investment advice. Please go to our website for a full list of disclosures and details of any client relationship we have. https://thedalesreport.com/website-te...

The latest Trade To Black podcast, hosts Shadd Dales and Anthony Varrell dive into major developments in the cannabis industry. Joining us is Peter Sack, Managing Director from Chicago Atlantic (NASDAQ: $REFI), who will discuss the latest earnings his company recently reported. Chicago Atlantic posted some notable numbers in their most recent earnings, including a total loan principal outstanding of $410.2 million across 30 portfolio companies and a portfolio weighted average yield to maturity of 17.2% as of December 31, 2024 .Peter also shares his insights on the latest developments involving Innovative Industrial Properties (NYSE: IIPR) and the Pharmacann story. Pharmacann, one of IIPR’s key tenants, has defaulted on rent for nine out of eleven leases, amounting to $2.7 million in March alone. This includes properties across states like New York, Illinois, and Pennsylvania. We’ll discuss the broader impact on the cannabis industry, and what this means for the overall industry.Plus, Shadd and Anthony will highlight news from last week involving a recent disclosure by SNDL Inc. (NASDAQ: SNDL) regarding its acquisition of 5.4% of High Tide’s (NASDAQ: HITI) common shares. High Tide’s CEO, Raj Grover, acknowledged the filing, stating that the company’s board will monitor the situation to safeguard shareholder value. While the reason behind SNDL’s investment is still unclear, some speculate it could be a move toward potential M&A discussions. Given SNDL’s track record in cannabis acquisitions—such as its purchase of The Valens Company—the possibility of a deal remains open.We’ll also talk Ohio’s cannabis sales for February, which hit $77.8M, reflecting a steady market despite a 25% price decline since August. Additionally, Michael Bronstein from the American Trade Association for Cannabis and Hemp will join us for the weekly Insiders Edge segment, to provide updates on Pennsylvania’s legalization efforts, where Gov. Josh Shapiro continues to push for adult-use marijuana reform.#cannabis #marijuana #cannabisstocks #sndl #hightide #cannabisindustry #weed #cannabisreform #cannabislegalization Want to see last week's recap?   • TDR’s Biggest Developments for the We...  Want to see more Cannabis Reform videos?   • DEA Bias Complicates Cannabis Resched...     • How The US Mistakenly Legalized Marij...     • Understanding Hemp vs. Cannabis: What...     • Why Trump Says Cannabis Legalization ...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:   / thedalesreport  Twitter:   / thedalesreport  Instagram:   / dalesreport  LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:[email protected] views on the Trade To Black podcast and the guests on this podcast are purely opinions. You should not treat any opinions expressed by us or our guests as investment advice. The views on this podcast are solely intended to be informational and are not investment advice. Please go to our website for a full list of disclosures and details of any client relationship we have. https://thedalesreport.com/website-te...

Shadd Dales and Anthony Varrell are joined by Shane Pennington, Partner at Porter Wright Morris & Arthur LLP, to discuss the big news involving the U.S. Drug Enforcement Administration (DEA) and its stance on marijuana rescheduling. Longstanding suspicions that the DEA is opposed to rescheduling marijuana from Schedule 1 to Schedule 3 under federal law have been confirmed by agency decisions made public during an ongoing lawsuit.According to DEA documents made public as part of a lawsuit brought by Doctors for Drug Policy Reform (DDPR), the federal drug agency considered a total of 163 applicants but selected only 25 based on still-unknown criteria. The DEA rejected participation requests from New York and Colorado officials, who supported rescheduling, and attempted to aid almost a dozen opponents of marijuana rescheduling. This is the fullest disclosure to date of the DEA’s actions during the marijuana rescheduling process.Join us for this in-depth discussion on what this means for cannabis rescheduling moving forward.Plus, Michael Bronstein from the American Trade Association for Cannabis & Hemp will join us to discuss several key topics, including the efforts of Florida Republican lawmakers to impose significant restrictions on ballot initiatives, which could impact marijuana legalization efforts next year. He will also touch on the recent advancement of a bill in Kentucky that would ban hemp-derived beverages until mid-2026, and the potential nationwide implications of this decision.

0:00:00 - DEA Bias in Rescheduling0:01:30 - Crypto & Cannabis Markets0:02:23 - DEA Bias ReactionsShane Pennington Interview0:03:04 - DEA Bias Details0:05:04 - Legal Strategy & Challenges0:08:33 - ALJ Hearing Implications0:12:37 - ALJ Process Status0:14:46 - New Administration Actions0:16:17 - Chevron Deference Discussion0:18:42 - DEA's Legal & Ethical Issues0:20:03 - Cannabis Rescheduling Politics0:23:40 - Cannabis Access & Urgency0:26:10 - DEA Decision TimelineMichael Bronstein Interview0:32:09 - Admin Hurdles in Legalization0:34:14 - Politics of Cannabis Reform0:35:10 - Economic Impact of Research0:36:14 - Public Opinion Shift0:38:16 - Social Change & Policy0:40:35 - Cannabis Access Today0:41:42 - Medical Cannabis Distribution0:44:01 - Cannabis Regulation Approaches0:47:19 - Hemp Laws: Georgia Case0:50:11 - Alcohol & Hemp Beverages0:56:25 - Hemp Regulation Challenges1:00:41 - Texas Senate Bill 31:02:27 - Florida’s Hemp Market#MarijuanaRescheduling #DEA #CannabisNews #DrugPolicy #MedicalMarijuana #CannabisReform #Podcast #Cannabis #Marijuana Want to see last week's recap?   • TDR’s Biggest Cannabis Developments f...  Want to see more Cannabis Reform videos?   • How The US Mistakenly Legalized Marij...     • Understanding Hemp vs. Cannabis: What...     • Why Trump Says Cannabis Legalization ...     • Warren Buffett’s Berkshire Hathaway I...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:   / thedalesreport  Twitter:   / thedalesreport  Instagram:   / dalesreport  LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:[email protected] views on the Trade To Black podcast and the guests on this podcast are purely opinions. You should not treat any opinions expressed by us or our guests as investment advice. The views on this podcast are solely intended to be informational and are not investment advice. Please go to our website for a full list of disclosures and details of any client relationship we have. https://thedalesreport.com/website-te...

Shadd Dales and Anthony Varrell take you to Fort Lauderdale, Florida, for an exclusive conversation with Sunburn Cannabis CEO Brady Cobb at the company’s flagship dispensary. Once you see this place, it’s easy to understand why Sunburn has become one of the top-quality cannabis brands in the state.Brady shares the evolution of Sunburn, which took off after acquiring MedMen stores in August 2022. The brand has since built its identity around a “quality over quantity” approach, deeply rooted in Florida’s culture and lifestyle.We also dive into the current state of Florida’s cannabis market post-Amendment 3. With price compression, increased cultivation, and retail expansion, competition is heating up. Could this lead to a major MSO bankruptcy within the next 18 months? We discuss that possibility.Brady also weighs in on the unregulated nature of Florida’s hemp market, stressing the urgent need for stricter regulations, including testing and packaging requirements.And finally, we touch on the bigger picture—cannabis rescheduling, federal legislation, and whether SAFE Banking could gain momentum in the coming months.It’s a must-listen episode covering everything from market dynamics and regulation to the future of the industry. Don’t miss it!0:00:00 Intro0:01:04 Store Design and Marketing Strategy0:03:43 Florida Cannabis Market Statistics0:04:34 Dispensary Design Philosophy0:06:20 Brand Expansion Strategy0:07:24 Medical vs. Recreational Cannabis0:08:12 Market Expansion and Cultivation Plans0:09:11 Amendment 3 Market Challenges0:10:41 Florida Licensing Landscape0:11:42 Hemp Regulation Discussion0:14:31 Regulatory Outlook for Cannabis0:16:32 Political Landscape for Cannabis0:18:46 Market Size and Potential0:22:56 Sunburn Brand Origin Story0:26:19 Closing Remarks#TradeToBlack #SunburnCannabis #BradyCobb #FortLauderdale #CannabisIndustry #FloridaCannabis #SpringBreak #HempRegulation #QualityOverQuantity #CannabisExpansion #CannabisReschedulingWant to see last week's recap?   • TDR’s Biggest Cannabis Developments f...  Want to see more Cannabis Reform videos?   • How The US Mistakenly Legalized Marij...     • Understanding Hemp vs. Cannabis: What...     • Why Trump Says Cannabis Legalization ...     • Warren Buffett’s Berkshire Hathaway I...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:   / thedalesreport  Twitter:   / thedalesreport  Instagram:   / dalesreport  LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:[email protected] views on the Trade To Black podcast and the guests on this podcast are purely opinions. You should not treat any opinions expressed by us or our guests as investment advice. The views on this podcast are solely intended to be informational and are not investment advice. Please go to our website for a full list of disclosures and details of any client relationship we have. https://thedalesreport.com/website-te...

Shadd Dales and Anthony Varrell are joined by former NBA player and CEO of Viola Brands, Al Harrington, along with Avicanna (TSX: AVCN) CEO, Aras Azadian.The episode discusses the partnership between Viola Brands, led by Al Harrington, and Avicanna, focusing on cannabis-based medicines. Harrington will highlight the changing stigma around cannabis and its benefits for athletes, noting the NBA's relaxed testing standards. The partnership aims to develop effective, THC-free CBD topicals for pain relief, backed by clinical trials. Aras Azadian will outline how the need for scientific evidence to legitimize cannabinoid-based medicines is what will be required for CBD brands moving forward. We’ll also learn how Al Harrington entered into the cannabis industry in 2011, where he was motivated by medicinal cannabis benefits inspired by his grandmother's experience by developing Viola Brands and Replay product line.In addition we’ll discuss the collaboration between Avicanna and Viola Brands where they focus on developing evidence-based, THC-free products for pain management and athlete recovery, expanding into international markets.Plus, and important topic on how the NBA is relaxing cannabis testing standards signal growing acceptance among athletes, and the importance of cannabis rescheduling, potential pharmaceutical developments, expanding research into cannabinoid applications for medical conditions like sleep, pain, and anxiety.0:00:00 - Podcast Introduction0:00:45 - Cannabis Industry Background0:01:11 - Guest Introductions0:02:07 - Cannabis Landscape in Texas0:03:31 - Industry Evolution0:04:39 - Sports and Cannabis0:06:27 - Partnership Origins0:08:23 - Replay Product Details0:11:52 - Player Receptiveness0:16:12 - Cannabis Rescheduling0:18:34 - Product Market Strategy0:21:03 - Medical Research0:23:06 - Viola Brands Vision0:24:19 - Podcast Conclusion#CannabisIndustry #TradeToBlack #ViolaBrands #Avicanna #CBD #MedicalResearch #CannabisInSports #PainRelief #CannabisStigma #THCFreeProducts #AlHarrington #cannabis #marijuana #NBAWant to see last week's recap?   • TDR’s Biggest Cannabis Developments f...  Want to see more Cannabis Reform videos?   • How The US Mistakenly Legalized Marij...     • Understanding Hemp vs. Cannabis: What...     • Why Trump Says Cannabis Legalization ...     • Warren Buffett’s Berkshire Hathaway I...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:   / thedalesreport  Twitter:   / thedalesreport  Instagram:   / dalesreport  LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:[email protected] views on the Trade To Black podcast and the guests on this podcast are purely opinions. You should not treat any opinions expressed by us or our guests as investment advice. The views on this podcast are solely intended to be informational and are not investment advice. Please go to our website for a full list of disclosures and details of any client relationship we have. https://thedalesreport.com/website-te...